Born in November 1975, Dr. Weijiang Zhao obtained his Bachelor's degree in Medical Imaging from Mudanjiang Medical College in 1999 and subsequently earned his Master's and Ph.D. degrees in Neurobiology from Capital Medical University in 2003 and 2007, respectively. From 2007 to 2009, he completed postdoctoral research at Cedars-Sinai Medical Center, UCLA, under the mentorship of Professor Shlomo Melmed, former president of the International Endocrine Society and the International Pituitary Society. During this time, he investigated the expression and function of Neuregulin 1 in the neuroendocrine system. In November 2009, he joined the Neuroscience Center at Shantou University Medical College, collaborating with German Academy of Sciences member Melitta Schachner on research involving phage display screening of human L1 antibodies for the treatment of spinal cord injury, experimental treatments for Alzheimer's disease, neuro-oncology mechanisms, and hypothalamic-pituitary regulation. He has led two projects funded by the National Natural Science Foundation of China and participated in five others. In October 2019, Dr. Zhao joined Wuxi Medical School, Jiangnan University, where he serves as the head of the Cell Biology Teaching and Research Section. He engages in neuroscience research and teaches undergraduate courses in clinical medicine, neuroscience, medical English, and cell biology. Professor Zhao has been dedicated to studying the regulatory mechanisms of the neuregulin family in the hypothalamic-pituitary axis, spinal cord injury, gliomas, pituitary tumors, and Alzheimer's disease. He has published nearly 80 papers, including over 50 SCI-indexed papers. He serves as an expert reviewer for the National Natural Science Foundation of China and the Ministry of Education dissertation review committee. He is also a reviewer for journals such asFrontiersseries,Biomaterials,BBA,Cancer Letters,Cell Death & Disease, andNeurochemistry International. Currently, he is on the editorial board ofExperimental and Therapeutic Medicineand has previously served as a youth editorial board member forNeural Regeneration Research. |
